|
|
(State or Other Jurisdiction of Incorporation)
|
(I.R.S. Employer Identification No.)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
||
Exhibit
Number |
|
Description
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
BERRY GLOBAL GROUP, INC.
(Registrant)
|
|||
|
By:
|
/s/ Jason K. Greene |
|
Dated: May 4, 2023 |
Name: |
Jason K. Greene |
|
Title: |
Executive Vice President, Chief Legal Officer and Secretary |
||
|
News Release
|
|
|
Berry’s Chairman and CEO Tom Salmon said, “Our business delivered solid second quarter and first half results with adjusted earnings per share growth of 4% and 7%, respectively. During the past several quarters, we have seen supply chain constraints continue to ease, prioritized structural cost improvements and continued our efforts to pivot our portfolio to high-value growth products across all of our businesses. Our cost actions include the rationalizing of 15 facilities across the world, moving business to more efficient cost facilities, and other labor cost reductions from improved productivity. These cost savings initiatives are expected to provide annualized cost savings of $115 million and we expect to realize $70 million in fiscal 2023. These internal actions helped to offset a 6% volume decline driven by destocking and general market softness. We continued our focus on driving long-term value for our shareholders and repurchased $155 million of shares, or another 2.1% of shares outstanding, in the second quarter, while also paying our quarterly dividend. We believe our shares remain undervalued and our repurchases reflect our confidence in the outlook of our business, our long-term strategy, and the strength of our operating model and cash flows. “We will continue to target key end markets which offer greater potential for differentiation and long-term growth, such as healthcare,
beauty, and foodservice. Additionally, we will continue to invest and expand our emerging market exposure while delivering highly desired innovative and sustainability-focused customer-linked products. Together, with these growth drivers,
we are making long-lasting structural cost improvements while advancing our strategic initiatives to exit 2023 a much stronger and more focused Company.”
|
March Quarter
|
March YTD
|
|||||||||||||||
GAAP results
|
2023
|
2022
|
2023
|
2022
|
||||||||||||
Net sales
|
$
|
3,288
|
$
|
3,775
|
$
|
6,348
|
$
|
7,348
|
||||||||
Operating income
|
301
|
341
|
511
|
570
|
||||||||||||
EPS (diluted)
|
1.42
|
1.50
|
2.27
|
2.36
|
March Quarter
|
Reported
|
Comparable
|
March YTD
|
Reported
|
Comparable
|
|||||||||||||||||||||||||||
Adjusted non-GAAP results
|
2023
|
2022
|
%
|
%
|
2023
|
2022
|
%
|
%
|
||||||||||||||||||||||||
Net sales
|
$
|
3,288
|
$
|
3,775
|
(13
|
%)
|
(10
|
%)
|
$
|
6,348
|
$
|
7,348
|
(14
|
%)
|
(10
|
%)
|
||||||||||||||||
Operating EBITDA
|
541
|
555
|
(3
|
%)
|
1
|
%
|
984
|
1,012
|
(3
|
%)
|
2
|
%
|
||||||||||||||||||||
Adjusted EPS (diluted)
|
1.96
|
1.93
|
2
|
%
|
4
|
%
|
3.26
|
3.18
|
3
|
%
|
7
|
%
|
(1)
|
Adjusted non-GAAP results exclude items not considered to be ongoing operations. In addition, comparable change % excludes the impacts of foreign currency
and recent divestitures. Further details related to non-GAAP measures and reconciliations can be found under our “Non-GAAP Financial Measures and Estimates” section or in reconciliation tables in this release. in millions of USD, except
per share data
|
•
|
Adjusted earnings per share range of $7.30 - $7.80
|
•
|
Cash flow from operations range of $1.4 - $1.5 billion; free cash flow range of $800 - $900 million
|
•
|
Anticipate returning at least $700 million of capital to shareholders through share repurchases and dividends
|
Quarterly Period Ended
|
Two Quarterly Periods Ended
|
|||||||||||||||
April 1, 2023
|
April 2, 2022
|
April 1, 2023
|
April 2, 2022
|
|||||||||||||
Net sales
|
$
|
3,288
|
$
|
3,775
|
$
|
6,348
|
$
|
7,348
|
||||||||
Costs and expenses:
|
||||||||||||||||
Cost of goods sold
|
2,682
|
3,154
|
5,224
|
6,192
|
||||||||||||
Selling, general and administrative
|
220
|
207
|
456
|
442
|
||||||||||||
Amortization of intangibles
|
60
|
65
|
120
|
133
|
||||||||||||
Restructuring and transaction activities
|
25
|
8
|
37
|
11
|
||||||||||||
Operating income
|
301
|
341
|
511
|
570
|
||||||||||||
Other expense
|
1
|
6
|
2
|
6
|
||||||||||||
Interest expense, net
|
79
|
71
|
150
|
142
|
||||||||||||
Income before income taxes
|
221
|
264
|
359
|
422
|
||||||||||||
Income tax expense
|
47
|
59
|
79
|
96
|
||||||||||||
Net income
|
$
|
174
|
$
|
205
|
$
|
280
|
$
|
326
|
||||||||
Basic net income per share
|
$
|
1.44
|
$
|
1.53
|
$
|
2.29
|
$
|
2.42
|
||||||||
Diluted net income per share
|
1.42
|
1.50
|
2.27
|
2.36
|
||||||||||||
Outstanding weighted average shares (in millions)
|
||||||||||||||||
Basic
|
120.7
|
133.8
|
122.2
|
134.6
|
||||||||||||
Diluted
|
122.5
|
136.9
|
123.3
|
138.0
|
||||||||||||
(in millions of USD)
|
April 1, 2023
|
October 1, 2022
|
||||||
Cash and cash equivalents
|
$
|
696
|
$
|
1,410
|
||||
Accounts receivable
|
1,751
|
1,777
|
||||||
Inventories
|
1,864
|
1,802
|
||||||
Other current assets
|
220
|
175
|
||||||
Property, plant, and equipment
|
4,612
|
4,342
|
||||||
Goodwill, intangible assets, and other long-term assets
|
7,470
|
7,450
|
||||||
Total assets
|
$
|
16,613
|
$
|
16,956
|
||||
Current liabilities, excluding current debt
|
2,308
|
2,831
|
||||||
Current and long-term debt
|
9,307
|
9,255
|
||||||
Other long-term liabilities
|
1,703
|
1,674
|
||||||
Stockholders’ equity
|
3,295
|
3,196
|
||||||
Total liabilities and stockholders' equity
|
$
|
16,613
|
$
|
16,956
|
Two Quarterly Periods Ended
|
||||||||
(in millions of USD)
|
April 1, 2023
|
April 2, 2022
|
||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
280
|
$
|
326
|
||||
Depreciation
|
279
|
284
|
||||||
Amortization of intangibles
|
120
|
133
|
||||||
Non-cash interest, net
|
(27
|
)
|
8
|
|||||
Settlement of derivatives
|
36
|
-
|
||||||
Deferred income tax
|
(51
|
)
|
(43
|
)
|
||||
Share-based compensation expense
|
30
|
28
|
||||||
Other non-cash operating activities, net
|
8
|
(14
|
)
|
|||||
Changes in working capital
|
(507
|
)
|
(736
|
)
|
||||
Net cash from operating activities
|
168
|
(14
|
)
|
|||||
Cash flows from investing activities:
|
||||||||
Additions to property, plant, and equipment, net
|
(385
|
)
|
(367
|
)
|
||||
Acquisition of business and other
|
(88
|
)
|
3
|
|||||
Net cash from investing activities
|
(473
|
)
|
(364
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Repayments on long-term borrowings
|
(583
|
)
|
(9
|
)
|
||||
Proceeds from long-term borrowings
|
500
|
244
|
||||||
Repurchase of common stock
|
(333
|
)
|
(351
|
)
|
||||
Proceeds from issuance of common stock
|
18
|
22
|
||||||
Dividends paid
|
(65
|
)
|
-
|
|||||
Other, net
|
11
|
-
|
||||||
Net cash from financing activities
|
(452
|
)
|
(94
|
)
|
||||
Effect of currency translation on cash
|
43
|
3
|
||||||
Net change in cash and cash equivalents
|
(714
|
)
|
(469
|
)
|
||||
Cash and cash equivalents at beginning of period
|
1,410
|
1,091
|
||||||
Cash and cash equivalents at end of period
|
$
|
696
|
$
|
622
|
||||
Non-U.S. GAAP Free Cash Flow:
|
||||||||
Cash flow from operating activities
|
$
|
168
|
$
|
(14
|
)
|
|||
Additions to property, plant, and equipment (net)
|
(385
|
)
|
(367
|
)
|
||||
Non-U.S. GAAP Free Cash Flow
|
$
|
(217
|
)
|
$
|
(381
|
)
|
Quarterly Period Ended April 1, 2023
|
||||||||||||||||||||
(in millions of USD)
|
Consumer Packaging - International
|
Consumer Packaging- North America
|
Health, Hygiene & Specialties
|
Engineered Materials
|
Total
|
|||||||||||||||
Net sales
|
$
|
1,059
|
$
|
774
|
$
|
677
|
$
|
778
|
$
|
3,288
|
||||||||||
Operating income
|
$
|
75
|
$
|
93
|
$
|
34
|
$
|
99
|
$
|
301
|
||||||||||
Depreciation and amortization
|
77
|
54
|
44
|
25
|
200
|
|||||||||||||||
Restructuring and transaction activities
|
12
|
7
|
5
|
1
|
25
|
|||||||||||||||
Other non-cash charges
|
10
|
2
|
1
|
2
|
15
|
|||||||||||||||
Operating EBITDA
|
$
|
174
|
$
|
156
|
$
|
84
|
$
|
127
|
$
|
541
|
Quarterly Period Ended April 2, 2022
|
||||||||||||||||||||
Reported net sales
|
$
|
1,139
|
$
|
880
|
$
|
822
|
$
|
934
|
$
|
3,775
|
||||||||||
Foreign currency and divestitures
|
(99
|
)
|
—
|
(7
|
)
|
(16
|
)
|
(122
|
)
|
|||||||||||
Comparable net sales (1)
|
$
|
1,040
|
$
|
880
|
$
|
815
|
$
|
918
|
$
|
3,653
|
||||||||||
Operating income
|
$
|
97
|
$
|
85
|
$
|
69
|
$
|
90
|
$
|
341
|
||||||||||
Depreciation and amortization
|
82
|
53
|
44
|
27
|
206
|
|||||||||||||||
Restructuring and transaction activities
|
5
|
2
|
—
|
1
|
8
|
|||||||||||||||
Other non-cash charges
|
(4
|
)
|
2
|
1
|
1
|
—
|
||||||||||||||
Foreign currency and divestitures
|
(15
|
)
|
—
|
(4
|
)
|
(2
|
)
|
(21
|
)
|
|||||||||||
Comparable operating EBITDA (1)
|
$
|
165
|
$
|
142
|
$
|
110
|
$
|
117
|
$
|
534
|
(1)
|
The prior year comparable basis change excludes the impacts of foreign currency and recent divestitures. Further details related to non-GAAP measures and reconciliations
can be found under our “Non-GAAP Financial Measures and Estimates” section or in reconciliation tables in this release.
|
Quarterly Period Ended
|
Two Quarterly Periods Ended
|
|||||||||||||||
April 1, 2023
|
April 2, 2022
|
April 1, 2023
|
April 2, 2022
|
|||||||||||||
Net income
|
$
|
174
|
$
|
205
|
$
|
280
|
$
|
326
|
||||||||
Add: other expense
|
1
|
6
|
2
|
6
|
||||||||||||
Add: interest expense
|
79
|
71
|
150
|
142
|
||||||||||||
Add: income tax expense
|
47
|
59
|
79
|
96
|
||||||||||||
Operating income
|
$
|
301
|
$
|
341
|
$
|
511
|
$
|
570
|
||||||||
Add: restructuring and transaction activities
|
25
|
8
|
37
|
11
|
||||||||||||
Add: other non-cash charges
|
15
|
—
|
37
|
14
|
||||||||||||
Adjusted operating income (2)
|
$
|
341
|
$
|
349
|
$
|
585
|
$
|
595
|
||||||||
Add: depreciation
|
140
|
141
|
279
|
284
|
||||||||||||
Add: amortization of intangibles
|
60
|
65
|
120
|
133
|
||||||||||||
Operating EBITDA (2)
|
$
|
541
|
$
|
555
|
$
|
984
|
$
|
1,012
|
||||||||
Net income per diluted share
|
$
|
1.42
|
$
|
1.50
|
$
|
2.27
|
$
|
2.37
|
||||||||
Other expense, net
|
0.01
|
0.04
|
0.02
|
0.04
|
||||||||||||
Restructuring and transaction activities
|
0.20
|
0.06
|
0.29
|
0.08
|
||||||||||||
Amortization of intangibles from acquisitions (1)
|
0.49
|
0.47
|
0.97
|
0.96
|
||||||||||||
Income tax impact on items above
|
(0.16
|
)
|
(0.14
|
)
|
(0.29
|
)
|
(0.27
|
)
|
||||||||
Foreign currency and divestitures
|
(0.05
|
)
|
(0.13
|
)
|
||||||||||||
Adjusted net income per diluted share (2)
|
$
|
1.96
|
$
|
1.88
|
$
|
3.26
|
$
|
3.05
|
Estimated Fiscal 2023
|
||||
Cash flow from operating activities
|
$
|
1,400-$1,500
|
||
Net additions to property, plant, and equipment
|
(600
|
)
|
||
Free cash flow (2)
|
$
|
800-$900
|
(1)
|
Amortization of intangibles from acquisition are added back to better align our calculation of adjusted EPS with peers.
|
(2)
|
Supplemental financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States (“GAAP”). These
non-GAAP financial measures should not be considered as alternatives to operating or net income or cash flows from operating activities, in each case determined in accordance with GAAP. Organic sales growth and comparable basis measures
exclude the impact of currency translation effects and acquisitions. These non-GAAP financial measures may be calculated differently by other companies, including other companies in our industry, limiting their usefulness as comparative
measures. Berry’s management believes that adjusted net income and other non-GAAP financial measures are useful to our investors because they allow for a better period-over-period comparison of operating results by removing the impact of
items that, in management’s view, do not reflect our core operating performance.
|